Overview
Hsu-lung Jen practices in Taiwan. Their top areas of expertise are Coronary Heart Disease and Percutaneous Coronary Intervention (PCI).
Their clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hsu-lung Jen
Is Hsu-lung Jen a top-rated expert for Percutaneous Coronary Intervention (PCI)?
MediFind is an objective health platform that identifies experts based on real-world data. Hsu-lung Jen is classified as an Experienced expert for Percutaneous Coronary Intervention (PCI), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hsu-lung Jen participate in research or clinical trials?
Yes. Hsu-lung Jen has published 10 articles and abstracts on conditions like Percutaneous Coronary Intervention (PCI). You can view a list of Hsu-lung Jen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Coronary Heart DiseaseJen isExperienced. Learn about Coronary Heart Disease.
- Percutaneous Coronary Intervention (PCI)